Skip to main content
OpenTrials
Completed

NCT Number: NCT01241175

The Effect of Intravenous Magnesium Sulfate on Intraocular Pressure Following Tracheal Intubation

The aim of this study is to assess the effect of preoperatively administered intra venous magnesium sulfate in attenuating pressure response to laryngoscopy and endotracheal intubation in adult patients scheduled for elective non ocular surgery

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–38 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Shiraz University of Medical Sciences

Shiraz, Fars, Iran

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 to 38 years old
  • ASA I
  • scheduled for elective ENT ambulatory surgeries under general anesthesia

Exclusion criteria

  • specific major hepatic, renal and cardio-vascular disease
  • known to have allergic reaction to magnesium sulphate or other drugs , -hypermagnesemia
  • hypocalcemia
  • anuria
  • heart block
  • pregnancy
  • any degree of renal insufficiency
  • digitalised patients
  • positive history of glaucoma or intra ocular hypertension
  • refused to participate

Treatment and study plan

Magnesium sulfate

Drug

normal saline

Drug

Primary outcomes

  1. Intra ocular pressure

Secondary outcomes

  1. blood pressure,heart rate

Sponsors and collaborators

Lead sponsor

Shiraz University of Medical Sciences

Other

Registry information

Important dates

First posted
Nov 16, 2010
Registry last updated
Nov 16, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.